Literature DB >> 8686512

The bone mineral status of patients with Marfan syndrome.

L Kohlmeier1, C Gasner, L K Bachrach, R Marcus.   

Abstract

Osteopenia at the hip and low total body calcium content have been reported in women with Marfan syndrome. Using dual X-ray absorptiometry (DXA), we evaluated the lumbar spine L2-L4 and proximal femur bone mineral density (BMD,/cm2) in 32 women and 16 children with Marfan syndrome. The women were 38 +/- 10 (SD) years old (23-58 years); their mean height was 178.7 +/- 8 cm. The children (9 boys and girls were 9.9-17.5 years old. Children were tall for their ages but of normal weight. All subjects were moderately active, without previous nontraumatic fracture. In the women, BMD was reduced at L2-L4, femoral neck (fnk), trochanter (tr), and intertrochanter (intr) (p < 0.0001-0.006), compared with age-predicted values. Z scores for L2-L4 and for the fnk, tr, and intr, were -0.59 +/- 1.06,-1.25 +/- 0.99,-1.03 +/- 0.91, respectively. The average hip axis length (HAL) of 11.5 +/- 0.093 cm was at the 80th percentile for women. No significant change was observed in 1 year follow-up BMD measurements in 13 women (fnk = -0.23 +/- 2.3%/year; L2-L4 = -0.43 +/- 1.57%/year). In Marfan children, BMD correlated with age, height, and pubertal development. Femoral neck BMG was reduced (Z = -0.74 +/- 1.22,p < 0.05) with a nonsignificant trend toward decreased BMD at L2-L4 (Z = 33 +/- 1.48). Resorption markers in Marfan women were normal and did not correlate with bone status. We conclude that women with Marfan syndrome have both axial and peripheral osteopenia as well as an increased HAL. This combination of findings likely increases substantially their long-term risk for hip fracture. Presence of osteopenia in Marfan children indicates that the skeletal deficits of Marfan syndrome may reflect inadequate bone acquisition.

Entities:  

Mesh:

Year:  1995        PMID: 8686512     DOI: 10.1002/jbmr.5650101017

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Luca Carta; Jason R Cook; Silvia Smaldone; Gabriella Siciliano; Aaron N Rifkin; Harry C Dietz; Daniel B Rifkin; Francesco Ramirez
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

2.  Microfibrils, elastin fibres and collagen fibres in the human intervertebral disc and bovine tail disc.

Authors:  Jing Yu; Uday Tirlapur; Jeremy Fairbank; Penny Handford; Sally Roberts; C Peter Winlove; Zhanfeng Cui; Jill Urban
Journal:  J Anat       Date:  2007-04       Impact factor: 2.610

3.  Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells.

Authors:  Natalina Quarto; Brian Leonard; Shuli Li; Melanie Marchand; Erica Anderson; Barry Behr; Uta Francke; Renee Reijo-Pera; Eric Chiao; Michael T Longaker
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-16       Impact factor: 11.205

4.  Assessment of bone mineral density in adults and children with Marfan syndrome.

Authors:  Philip F Giampietro; Margaret Peterson; Robert Schneider; Jessica G Davis; Cathleen Raggio; Elizabeth Myers; Stephen W Burke; Oheneba Boachie-Adjei; Charles M Mueller
Journal:  Osteoporos Int       Date:  2003-07-03       Impact factor: 4.507

5.  Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

Authors:  Steven D Rhodes; Xiaohua Wu; Yongzheng He; Shi Chen; Hao Yang; Karl W Staser; Jiapeng Wang; Ping Zhang; Chang Jiang; Hiroki Yokota; Ruizhi Dong; Xianghong Peng; Xianlin Yang; Sreemala Murthy; Mohamad Azhar; Khalid S Mohammad; Mingjiang Xu; Theresa A Guise; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

6.  Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism.

Authors:  Kerstin Tiedemann; Iris Boraschi-Diaz; Irina Rajakumar; Jasvir Kaur; Peter Roughley; Dieter P Reinhardt; Svetlana V Komarova
Journal:  J Cell Sci       Date:  2013-09-15       Impact factor: 5.285

7.  Bone mineral density determinations by dual-energy x-ray absorptiometry in the management of patients with Marfan syndrome--some factors which affect the measurement.

Authors:  Philip F Giampietro; Margaret G E Peterson; Robert Schneider; Jessica G Davis; Stephen W Burke; Oheneba Boachie-Adjei; Charles M Mueller; Cathleen L Raggio
Journal:  HSS J       Date:  2007-02

Review 8.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

9.  Recapitulating and Correcting Marfan Syndrome in a Cellular Model.

Authors:  Jung Woo Park; Li Yan; Chris Stoddard; Xiaofang Wang; Zhichao Yue; Leann Crandall; Tiwanna Robinson; Yuxiao Chang; Kyle Denton; Enqin Li; Bin Jiang; Zhenwu Zhang; Kristen Martins-Taylor; Siu-Pok Yee; Hong Nie; Feng Gu; Wei Si; Ting Xie; Lixia Yue; Ren-He Xu
Journal:  Int J Biol Sci       Date:  2017-04-10       Impact factor: 6.580

10.  Assessment of bone mineral status in children with Marfan syndrome.

Authors:  Monica Grover; Nicola Brunetti-Pierri; John Belmont; Kelly Phan; Alyssa Tran; Roman J Shypailo; Kenneth J Ellis; Brendan H Lee
Journal:  Am J Med Genet A       Date:  2012-08-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.